Connect Biopharma Holdings (CNTB) Asset Utilization Ratio (2025 - 2026)

Connect Biopharma Holdings (CNTB) posted Asset Utilization Ratio of 0.0 for Q1 2026, up 286.93% sequentially from 0.0 in Q4 2025.

Connect Biopharma Holdings (CNTB) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Connect Biopharma Holdings has reported Asset Utilization Ratio for 2 years, with the latest figure at 0.0 in Q1 2026.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (changed N/A YoY) and the FY2025 annual result came in at 0.0, down 99.64% from the prior year.
Asset Utilization Ratio improved to 0.0 in Q1 2026 per CNTB's latest filing, from 0.0 in the prior quarter.
Over five years, Asset Utilization Ratio peaked at 0.02 in Q2 2025 and troughed at 0.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	138.93 Bn	131.07 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.91 Bn	77.92 Bn	3.93 Bn	0.38
3	Argenx Se	64.98 Bn	59.80 Bn	1.37 Bn	-
4	Moderna	58.86 Bn	53.72 Bn	52.00 Mn	0.20
5	BeOne Medicines	42.03 Bn	36.93 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.54 Bn	28.23 Bn	992.69 Mn	0.90
7	BioNTech SE	27.88 Bn	9.49 Bn	668.28 Mn	0.13
8	Insmed	27.44 Bn	26.28 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.35 Bn	26.51 Bn	-	0.13
10	Connect Biopharma Holdings	147.15 Mn	147.15 Mn	-	0.06

Download Data